126 related articles for article (PubMed ID: 25119360)
21. Detection of circulating antigens and parasite specific antibodies in filariasis.
Abdullah WO; Oothuman P; Yunus H
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():31-6. PubMed ID: 7973943
[TBL] [Abstract][Full Text] [Related]
22. Protective efficacy of a cloned Brugia malayi antigen in a mouse model of microfilaremia.
Kazura JW; Maroney PA; Pearlman E; Nilsen TW
J Immunol; 1990 Oct; 145(7):2260-4. PubMed ID: 2398279
[TBL] [Abstract][Full Text] [Related]
23. Identification of a highly immunoreactive epitope of Brugia malayi TPx recognized by the endemic sera.
Madhumathi J; Prince PR; Gayatri SC; Aparnaa R; Kaliraj P
J Parasitol; 2010 Dec; 96(6):1228-9. PubMed ID: 21158641
[TBL] [Abstract][Full Text] [Related]
24. Human antibody responses to Brugia malayi antigens in brugian filariasis.
Zhang S; Li B; Weil GJ
Int J Parasitol; 1999 Mar; 29(3):429-36. PubMed ID: 10333326
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.
Verma SK; Bansal I; Vedi S; Saxena JK; Katoch VM; Bhattacharya SM
Parasitol Res; 2008 Feb; 102(3):481-9. PubMed ID: 18064491
[TBL] [Abstract][Full Text] [Related]
26. Identification of 38kDa Brugia malayi microfilarial protease as a vaccine candidate for lymphatic filariasis.
Krithika KN; Dabir P; Kulkarni S; Anandharaman V; Reddy MV
Indian J Exp Biol; 2005 Sep; 43(9):759-68. PubMed ID: 16187525
[TBL] [Abstract][Full Text] [Related]
27. Differential recognition of Brugia malayi antigens by bancroftian filariasis sera.
Parab PB; Rajasekariah GR; Carvalho PA; Subrahmanyam D
Indian J Med Res; 1990 Mar; 91():138-43. PubMed ID: 2188906
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
[TBL] [Abstract][Full Text] [Related]
29. Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.
Dakshinamoorthy G; Munirathinam G; Stoicescu K; Reddy MV; Kalyanasundaram R
PLoS One; 2013; 8(10):e77394. PubMed ID: 24146990
[TBL] [Abstract][Full Text] [Related]
30. Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis.
Dissanayake S; Perler FB; Xu M; Southworth MW; Yee CK; Wang S; Dreyer G; Watawana L; Kurniawan L; Fuhrman JA
Am J Trop Med Hyg; 1995 Sep; 53(3):289-94. PubMed ID: 7573715
[TBL] [Abstract][Full Text] [Related]
31. Recombinant Brugia malayi pepsin inhibitor (rBm33) exploits host signaling events to regulate inflammatory responses associated with lymphatic filarial infections.
Sreenivas K; Kalyanaraman H; Babu S; Narayanan RB
Microb Pathog; 2017 Nov; 112():195-208. PubMed ID: 28942176
[TBL] [Abstract][Full Text] [Related]
32. Primary structure of and immunoglobulin E response to the repeat subunit of gp15/400 from human lymphatic filarial parasites.
Paxton WA; Yazdanbakhsh M; Kurniawan A; Partono F; Maizels RM; Selkirk ME
Infect Immun; 1993 Jul; 61(7):2827-33. PubMed ID: 8514385
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models.
Vedi S; Dangi A; Hajela K; Misra-Bhattacharya S
Vaccine; 2008 Nov; 26(47):5997-6005. PubMed ID: 18817835
[TBL] [Abstract][Full Text] [Related]
34. A Brugia malayi antigen specifically recognized by infected individuals.
Rahmah N; Anuar AK; A'shikin AN; Lim BH; Mehdi R; Abdullah B; Zurainee MN
Biochem Biophys Res Commun; 1998 Sep; 250(3):586-8. PubMed ID: 9784388
[TBL] [Abstract][Full Text] [Related]
35. Immune responses to recombinant Brugia malayi pepsin inhibitor homolog (Bm-33) in patients with human lymphatic filariaisis.
Krushna NS; Shiny C; Manokaran G; Elango S; Babu S; Narayanan RB
Parasitol Res; 2011 Feb; 108(2):407-15. PubMed ID: 20927633
[TBL] [Abstract][Full Text] [Related]
36. The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination.
Ramachandran S; Kumar MP; Rami RM; Chinnaiah HB; Nutman T; Kaliraj P; McCarthy J
Microbiol Immunol; 2004; 48(12):945-55. PubMed ID: 15611611
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.
Madhumathi J; Prince PR; Anugraha G; Kiran P; Rao DN; Reddy MV; Kaliraj P
Vaccine; 2010 Jul; 28(31):5038-48. PubMed ID: 20653106
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Brugia malayi antigenic peptides: candidates for synthetic vaccine design against lymphatic filariasis.
Gomase VS; Chitlange NR; Changbhale SS; Kale KV
Protein Pept Lett; 2013 Aug; 20(8):864-87. PubMed ID: 23537185
[TBL] [Abstract][Full Text] [Related]
39. Induction of protection against Brugia malayi infection in jirds by microfilarial antigens.
Kazura JW; Cicirello H; McCall JW
J Immunol; 1986 Feb; 136(4):1422-6. PubMed ID: 3944460
[TBL] [Abstract][Full Text] [Related]
40. Immune Response to
Hameed A; Natarajan M; Jabbar S; Dhanasekaran JJ; Kumar K; Sivanesan S; Kron M; Dhanasekaran A
Lymphat Res Biol; 2019 Aug; 17(4):447-456. PubMed ID: 30570354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
